Kewaunee Scientific (KEQU) vs TriSalus Life Sciences (TLSI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
TriSalus Life Sciences (TLSI) has outperformed Kewaunee Scientific (KEQU) over the past year, losing 14.8% versus a loss of 22.8%. Over five years, KEQU leads with a +156.2% price change compared with -58.3% for TLSI. TriSalus Life Sciences is the larger company by market cap ($250.0 million vs $97.8 million), about 2.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KEQU | TLSI |
|---|---|---|
| Share price | $33.79 | $4.06 |
| Market cap | $97.83M | $249.99M |
| 1-day change | -0.09% | -1.69% |
| YTD return | -9.60% | -40.83% |
| 1-year return | -22.84% | -14.85% |
| 5-year return | +156.21% | -58.28% |
| P/E ratio (TTM) | 12.24 | — |
| Forward P/E | 15.64 | — |
| EPS (TTM) | $2.76 | $-1.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $46.57 | $7.95 |
| 52-week low | $32.00 | $2.20 |
| Distance from 52-week high | -27.44% | -48.93% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +156.16% |
| Average volume | 4.22K | 275.38K |
| Shares outstanding | 2.90M | 61.57M |
| Employees | 1,231 | 102 |
| Sector | Industrials | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TriSalus Life Sciences is about 2.6 times larger than Kewaunee Scientific by market value ($249.99M vs $97.83M).
- The two companies sit in different sectors: Kewaunee Scientific in Industrials and TriSalus Life Sciences in Health Care.
About Kewaunee Scientific
KEQU stock →Kewaunee Scientific Corporation, together with its subsidiaries, designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products in the United States and internationally. It operates through two segments, Lab Products Group (LPG) and International.
Industrials · Medical Specialities · 1,231 employees
About TriSalus Life Sciences
TLSI stock →TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States.
Health Care · Medical Specialities · 102 employees
KEQU vs TLSI FAQ
Which is bigger, Kewaunee Scientific or TriSalus Life Sciences?
TriSalus Life Sciences (TLSI) is larger, with a market capitalization of $249.99M compared with $97.83M for Kewaunee Scientific (KEQU).
Which stock has performed better over the past year, KEQU or TLSI?
TLSI returned -14.85% over the past 12 months, compared with -22.84% for KEQU (price return, excluding dividends). Past performance does not predict future results.
Are Kewaunee Scientific and TriSalus Life Sciences in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Industrials sector.